Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug. This would see it face fewer restrictions on research and open up tax breaks for companies in the field. This decision is a major win for cannabis stocks and it resulted in many shares climbing higher during no ...

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ:CGC) saw their shares rise dramatically yesterday. As InvestorPlace’s Shrey Dua reported, President Joe Biden’s administration is moving to reschedule marijuana as a Schedule III substance. At the moment, cannabis carries the tougher Schedule I classification. With the decision potentially opening doors, CGC stock call options look mighty tempting. Fundamentally, the Schedule III downgrade would put marijuana on the same legal ...

OlegMalyshev Listen here or on the go via Apple Podcasts and Spotify. Mario Naric, CEO and Founder of Motif Labs, discusses being in the shakeout phase of cannabis in Canada (1:00). Staying private while public companies suffer (5:25). How to grow market share in Canada (12:53). Near-term reality for big Canadian LPs like Tilray and Canopy Growth (18:00). Different products for different markets within US and Canada (23:20). Where should investors allocate their capital in this space? (40:40) Transcript Ren ...

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well. The continued change in public opinion in favor of legalization might imply that it could have a chance of happening relatively soon at the federal level. With the presidential election due later this year, it’s a good time to look at cannabis stocks to buy for multibagger returns. While there are growi ...

Is Canopy Growth closer to entering the U.S. cannabis market? Canopy Growth (CGC 2.41%) is moving ahead with its plans for Canopy USA. After shareholders voted overwhelmingly in favor of its latest growth strategy for the U.S. pot market, the company is ready to take the next steps. Here's a look at what will those steps be, what they mean for investors, and whether these developments make Canopy Growth a better buy moving forward. What's next for Canopy Growth? Now that it has obtained shareholder approval ...

If you’re wondering what stocks to sell this quarter, you’re in the right place. Nothing lasts forever, not even stocks. During a 2018 all-hands meeting, Amazon (NASDAQ:AMZN) founder and then CEO Jeff Bezos famously said: “I predict one day Amazon will fail. Amazon will go bankrupt.” Apple (NASDAQ:AAPL) was on the verge of going bankrupt in 1997 before rival Microsoft (NASDAQ:MSFT) saved the then struggling company with a $150 million investment. History is littered with once famous companies and stocks tha ...

大麻行业投资策略 - 大麻行业已经迅速成为股市中的一个重要领域，吸引了各种投资者[1] - 大麻股票以其波动性而闻名，受到监管变化和政治动态的影响很大[1] - 投资大麻股票需要精明的投资策略，考虑到其固有的不可预测性[1] 投资策略建议 - 长期投资方法可以在大麻市场成熟时保护投资者免受短期波动的影响，并提供可观的回报[2] - 技术分析在波动的股市中抓住买卖机会非常有价值[2] 研究与风险管理 - 进行更多研究可以在投资时获得更好的信息[3] - 在权衡风险与回报时，拥有一个游戏计划或交易策略非常重要[3] - 有效管理风险在大麻股票波动的世界中至关重要[3] 大麻行业趋势 - 目前大麻行业正在增长并显示出持续成功的迹象[3] 大麻股票公司动态 - Canopy Growth Corporation是投资者关注的一家大麻股票公司[4] - Cronos Group Inc.宣布推出了其首款巧克力食品[8] - Tilray Brands, Inc.宣布推出了新的大麻花产品[10]

大麻行业发展 - 美国和德国分别在4/20庆祝日前后推进大麻合法化，对大麻行业发展具有重要意义[1][2] - 大麻股票市场仍处于高增长领域，具有较小的市值和较高的波动性，对于愿意承担市场风险以期望从法律变化中获利的投资者来说，大麻股票可能存在投资机会[3] Canopy Growth - Canopy Growth (NASDAQ:CGC)作为大麻股票市场的领头羊，其股价波动较大，公司计划进入德国市场，并通过新类别的可交换股票扩大业务规模，吸引更多投资者的关注[4][5][6] - Canopy Growth作为全球市值最大的大麻公司，其业绩可能成为其他大麻股票的领先指标[7] IM Cannabis - IM Cannabis (NASDAQ:IMCC)是一家在以色列和德国运营的医用大麻公司，与Avant Brands签署了授权协议，将在德国医用大麻市场推出BLK MKTTM品牌，吸引投资者的关注[8][9][10] Innovative Industrial Properties - Innovative Industrial Properties (NYSE:IIPR)是一家房地产投资信托公司，通过收购、拥有和管理专门租赁给州许可的大麻运营商的特殊物业来实现盈利，其稳定的股价和丰厚的股息吸引投资者的注意[11][12][13]

公司交易 - Canopy Growth宣布将Greenstar的可转换债券转换为可交换股份，减少了C$100MM的总债务余额[1] - Canopy Growth与Greenstar和CBG Holdings LLC进行了交易，将17,149,925普通股换成了17,149,925可交换股份[1] - Canopy Growth与Greenstar签订了交换协议，将C$81.2百万的可转换债券转换为9,111,549可交换股份[9] 公司治理 - CBG、Greenstar和Canopy Growth终止了投资者权益协议，CBG Group不再持有治理权利[3] - CBG提名的董事们决定辞去董事会职务，包括Ms. Schmeling和Mr. Sabia[4] 公司发展 - Canopy Growth致力于通过创新产品和优质大众品牌，如Doja、7ACRES、Tweed和Deep Space，提高人们的生活质量[12] - Canopy Growth通过拥有Acreage Holdings, Inc.、Wana Brands和Jetty Extracts等公司的权益，建立了一个全面的生态系统，以实现美国大麻市场的机遇[13] - Canopy Growth通过社会公平、负责任使用和社区再投资，引领行业向前发展，致力于让大麻被理解和欢迎，以实现更大的福祉和生活提升[14]

Among the unlikely winners that are once again seeing strong interest in today’s market, Canopy Growth (NASDAQ:CGC) is on a tear. Shares of CGC stock are up a whopping 25% in early afternoon trading, prompting questions of whether this stock is due for a short squeeze. With short interest as a percentage of the company’s float sitting at about 15%, it’s clear many in the market are taking the other side of this move. That said, when a stock is surging in this magnitude, short sellers can see their trades bl ...